EPGL has declined a $6mm offer by an Investment Banker to purchase 1/3 of Company's authorized shares.
The team also discussed new products from EPGL currently in R&D and doctor training for the upcoming MPDD release in 2013.
The call brought together medical professionals from both coasts, who are already on or will be joining the EPGL team shortly.
EPGL Medical Advisory Team members have concluded their first strategic conference call. The team discussed distribution channels...